News

1

Health worker taking finger prick blood test from child in Brazil

Brazil becomes the first malaria-endemic country to register single-dose tafenoquine for children with relapsing malaria

blood smears in a clinic

WHO call for public consultation on preferred product characteristics (PPCs) on tests for risk of P. vivax relapse

Mother holding young child at home

Brazil becomes the first malaria-endemic country to adopt single-dose tafenoquine and STANDARD G6PD Test for the treatment of relapsing Plasmodium vivax malaria

Screen shot of opening film sequence "From Science to Real Life"

MMV’s film on real-world tafenoquine study wins advocacy award at the 7th annual ISNTD festival

Agents pass along breeding ground in Nossa Vitoria

Regional initiatives and evidence-generation efforts to eliminate P. vivax malaria in Latin America

Single-dose tafenoquine 150mg tablets in palm of hand

Colombia approves single-dose medicine to prevent relapse of P. vivax malaria

healthworkers participating in a training.

Start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol in Thailand

Meeting participants looking at camera

Event Highlights: The Indo-Pacific Regulatory Strengthening Program (RSP) Forum, 2022

PAVE meeting participants facing the camera

Highlights from the Partnership for Vivax Elimination (PAVE) Greater Mekong Subregion (GMS) Country Coordinator Experience Exchange

Speakers at the Symposium

Exploring new tools for P. vivax elimination in Brazil

Photo of the poster

Event Highlights from the 2022 International Conference on Plasmodium vivax Research (ICPvR)

children sitting under a mosquito bed net.

Single-dose Kozenis (tafenoquine) approved for children with Plasmodium vivax malaria by Australian Therapeutic Goods Administration

Pages

1

Events